Pennington receives $9.2 million grant renewal
“Our interdisciplinary approach has allowed for a comprehensive evaluation of botanicals — specifically on pathogenic processes,” Prather said. By 2020, she said, BRC researchers will focus on botanicals' ability to promote metabolic resiliency and ...
LSU The Reveille - Mon, 05 Oct 2015 16:13

National Molecular Genetics Lab for Cancer Research opens in Belarus
According to department head Viktor Matusevich, in tumor cells changes occur in genes, as result of which pathologic proteins get into blood, urine, lymph, etc. and are determined in very small quantities. "In modern oncology this is taken into account ...
Belarus News (BelTA) - Wed, 07 Oct 2015 04:03

Exelixis to Host Investor/Analyst Webcast During European Cancer Congress 2015
These receptor tyrosine kinases are involved in both normal cellular function and in pathologic processes such as oncogenesis, metastasis, tumor angiogenesis, and maintenance of the tumor microenvironment. COMETRIQ® (cabozantinib capsules) is ...
MarketWatch - Tue, 22 Sep 2015 14:00

Nephrology research—the past, present and future
Important advances have been made in basic and clinical nephrology research over the past decade, with improved pathological insights into various disease processes and the introduction of new treatments for diseases such as atypical haemolytic uraemic ... - Mon, 28 Sep 2015 22:26

Children with autism spectrum disorders, who improved with a luteolin ...
The role of neurotensin in physiologic and pathologic processes. Curr Opin Endocrinol Diabetes Obes 2011; 18: 75–82. | Article | PubMed | CAS |; Tsilioni I, Dodman N, Petra AI, Taliou A, Francis K, Moon-Fanelli AA et al. Elevated serum neurotensin and ... - Tue, 29 Sep 2015 09:41

FDA Actions for RCC and ITP Drugs
The drug works by inhibiting the activity of tyrosine kinases including MET, VEGF receptors, AXL, and RET, which are involved in both normal cellular function and pathologic processes including oncogenesis, metastasis, tumor angiogenesis, and ...
LWW Journals - Tue, 15 Sep 2015 15:07

Promising New Cancer Treatment . Galectin Therapeutics nasdaq: GALTDennis O'Neill
Galectins, a class of proteins made by many cells in the body, are important therapeutic targets because they are the mediators of fundamental biologic mechanisms in pathological processes. Scientists at Galectin Therapeutics are renowned experts in ...
LinkedIn - Sun, 13 Sep 2015 15:00

Bayer to Showcase Data from Growing Oncology Franchise at ECC2015 in Vienna
Stivarga is an inhibitor of multiple kinases involved in normal cellular functions and in pathologic processes such as oncogenesis, tumor angiogenesis and maintenance of the tumor microenvironment.2. Stivarga is a compound developed by Bayer. In 2011 ...
PR Newswire (press release) - Sun, 13 Sep 2015 23:30

1  2  3  4  5  6  7  8    ->

We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014